Chris Lau
All posts from Chris Lau
Chris Lau in Value Stocks,

The Truth About the EpiPen Price Hike (Humor)

Mylan's CEO promptly responded to H. Clinton's criticism of price hikes for EpiPen. The company will cut prices by up to 50% in certain circumstances. The CEO deflected the issue of higher prices, shifting the blame on the medical system.

Lobbying is the true issue. This resulted in senators actually passing a law requiring schools to buy these branded EpiPens.

It is "for the kids."

That Pfizer supplies Mylan with EpiPens for distribution also owns the company that manufactures the generic. Mylan's price increases are due, in part, to Pfizer hiking prices it supplies. Pfizer also benefits as Mylan gains market share.